Your browser doesn't support javascript.
loading
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Mariani, Antoine; Zaanan, Aziz; Glehen, Olivier; Karoui, Mehdi.
Affiliation
  • Mariani A; Department of Digestive Surgery, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Université Paris Cité, Paris, France. a.mariani@hotmail.fr.
  • Zaanan A; Department of Digestive Oncology, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Université Paris Cité, Paris, France.
  • Glehen O; Surgical Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
  • Karoui M; Department of Digestive Surgery, Assistance Publique Hôpitaux de Paris, Georges Pompidou University Hospital, Université Paris Cité, Paris, France.
Ann Surg Oncol ; 30(2): 816-817, 2023 02.
Article in En | MEDLINE | ID: mdl-36383333
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peritoneal Neoplasms / Stomach Neoplasms Limits: Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peritoneal Neoplasms / Stomach Neoplasms Limits: Humans Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: France